Alpha Teknova, Inc. (NASDAQ:TKNO) Short Interest Update

Alpha Teknova, Inc. (NASDAQ:TKNO) was the recipient of a large drop in short interest in August. As of August 31st, there was short interest totalling 268,900 shares, a drop of 19.4% from the August 15th total of 333,800 shares. Approximately 2.6% of the shares of the stock are short sold. Based on an average trading volume of 600,700 shares, the short-interest ratio is presently 0.4 days.

Analyst Ratings Changes

Separately, Stephens reissued an “overweight” rating and issued a $5.00 target price on shares of Alpha Teknova in a research note on Wednesday, July 10th.

Insider Buying and Selling at Alpha Teknova

In related news, major shareholder Telegraph Hill Partners Iv, L. bought 12,096,773 shares of the business’s stock in a transaction that occurred on Friday, July 12th. The stock was bought at an average cost of $1.24 per share, for a total transaction of $14,999,998.52. Following the completion of the transaction, the insider now owns 11,126,929 shares of the company’s stock, valued at $13,797,391.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Alpha Teknova news, major shareholder Telegraph Hill Partners Iv, L. purchased 12,096,773 shares of the stock in a transaction on Friday, July 12th. The stock was acquired at an average cost of $1.24 per share, with a total value of $14,999,998.52. Following the completion of the purchase, the insider now directly owns 11,126,929 shares of the company’s stock, valued at approximately $13,797,391.96. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Matthew Lowell purchased 40,322 shares of the business’s stock in a transaction on Friday, July 12th. The shares were acquired at an average price of $1.24 per share, with a total value of $49,999.28. Following the completion of the transaction, the chief financial officer now owns 128,376 shares of the company’s stock, valued at $159,186.24. The disclosure for this purchase can be found here. Insiders have acquired a total of 12,217,740 shares of company stock valued at $15,149,998 in the last 90 days. Corporate insiders own 15.20% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. State Board of Administration of Florida Retirement System bought a new position in shares of Alpha Teknova during the first quarter valued at approximately $35,000. Redmile Group LLC increased its position in Alpha Teknova by 6.5% during the 1st quarter. Redmile Group LLC now owns 171,453 shares of the company’s stock valued at $434,000 after buying an additional 10,448 shares in the last quarter. FourWorld Capital Management LLC purchased a new position in Alpha Teknova during the first quarter valued at $135,000. Finally, Conestoga Capital Advisors LLC boosted its holdings in Alpha Teknova by 81.6% in the second quarter. Conestoga Capital Advisors LLC now owns 453,899 shares of the company’s stock worth $622,000 after acquiring an additional 203,950 shares in the last quarter. 13.81% of the stock is owned by hedge funds and other institutional investors.

Alpha Teknova Stock Performance

NASDAQ:TKNO opened at $4.40 on Tuesday. The company has a quick ratio of 3.28, a current ratio of 4.76 and a debt-to-equity ratio of 0.16. The firm’s fifty day simple moving average is $3.73 and its 200 day simple moving average is $2.64. The stock has a market cap of $179.62 million, a P/E ratio of -4.19 and a beta of 0.43. Alpha Teknova has a twelve month low of $1.15 and a twelve month high of $5.45.

Alpha Teknova (NASDAQ:TKNO) last released its earnings results on Tuesday, August 13th. The company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.03. The company had revenue of $9.61 million during the quarter, compared to analysts’ expectations of $9.50 million. Alpha Teknova had a negative return on equity of 37.00% and a negative net margin of 98.08%. During the same quarter last year, the business posted ($0.25) EPS. As a group, research analysts predict that Alpha Teknova will post -0.54 EPS for the current year.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.